India's Indoco Remedies gains after UK drug regulator inspection finds no major observations
BUZZ-India's Indoco Remedies gains after UK drug regulator inspection finds no major observations ** Shares of Indoco Remedies INRM.NS surge 13% to 261.10 rupees
** Drugmaker says UK Medicines and Healthcare products Regulatory Agency inspection of its Goa facility concluded with no critical or major observations
** Adds, inspection was conducted from September 7 to September 9
** More than 4.4 million shares traded so far, about 5.4x 30-day average volume - LSEG compiled data
** Stock up 11.3% YTD
(Reporting by Payel Das in Bengaluru)
Recent news on INDOCO REMEDIES
See all newsBrief: Indoco Remedies Says UK MHRA Inspects Goa Facility From Sept 7 To Sept 9, 2026
India's Indoco Remedies gains after UK drug regulator inspection finds no major observations
India's Indoco Remedies slides after FDA inspection ends with seven observations
Brief: Indoco Remedies Appoints Aditi Panandikar As MD
Brief: Indoco Remedies June-Quarter Consol Net Profit 649.9 Million Rupees